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Abstract
Background: Four traditional Korean medicinal herbs which act in retarding the aging process, Polygonum
multiflorum Thunb., Rehmannia glutinosa (Gaertn) Libosch., Polygala tenuifolia Willd., and Acorus gramineus Soland.,
were prepared by systematic investigation of Dongeuibogam (Treasured Mirror of Eastern Medicine), published in
the early 17th century in Korea. This study was performed to evaluate beneficial effects of four herbal mixture
extract (PMC-12) on hippocampal neuron and spatial memory.
Methods: High performance liquid chromatography (HPLC) analysis was performed for standardization of PMC-12.
Cell viability, lactate dehydrogenase, flow cytometry, reactive oxygen species (ROS), and Western blot assays were
performed in HT22 hippocampal cells and immunohistochemistry and behavioral tests were performed in a mouse
model of focal cerebral ischemia in order to observe alterations of hippocampal cell survival and subsequent
memory function.
Results: In the HPLC analysis, PMC-12 was standardized to contain 3.09 % 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside,
0.35 % 3′,6-disinapoyl sucrose, and 0.79 % catalpol. In HT22 cells, pretreatment with PMC-12 resulted in significantly
reduced glutamate-induced apoptotic cell death. Pretreatment with PMC-12 also resulted in suppression of ROS
accumulation in connection with cellular Ca2+ level after exposure to glutamate. Expression levels of phosphorylated
p38 mitogen-activated protein kinases (MAPK) and dephosphorylated phosphatidylinositol-3 kinase (PI3K) by glutamate
exposure were recovered by pretreatment with either PMC-12 or anti-oxidant N-acetyl-L-cysteine (NAC). Expression
levels of mature brain-derived neurotrophic factor (BDNF) and phosphorylated cAMP response element binding protein
(CREB) were significantly enhanced by treatment with either PMC-12 or NAC. Combination treatment with PMC-12,
NAC, and intracellular Ca2+ inhibitor BAPTA showed similar expression levels. In a mouse model of focal cerebral
ischemia, we observed higher expression of mature BDNF and phosphorylation of CREB in the hippocampus and
further confirmed improved spatial memory by treatment with PMC-12.
Conclusions: Our results suggest that PMC-12 mainly exerted protective effects on hippocampal neurons through
suppression of Ca2+-related ROS accumulation and regulation of signaling pathways of p38 MAPK and PI3K associated
with mature BDNF expression and CREB phosphorylation and subsequently enhanced spatial memory.
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Background
Due to an increase in life expectancy and the elderly
population, memory and cognitive impairments includ-
ing dementia have become a major public health prob-
lem [1]. Hippocampal neuronal death is a major factor
in the progress of memory impairment in many brain
disorders [2, 3]. Prevention of hippocampal neuronal
deaths provides a potential new therapeutic strategy to
ameliorate memory and cognitive impairment of many
neurological disorders. HT22 hippocampal cell line, which
lacks a functional glutamate receptor, is valuable for study-
ing molecular mechanism of memory deficits [2, 4].
Exposure of HT22 hippocampal cells to glutamate
shows neurotoxicity through oxidative stress rather than
N-methyl-D-aspartate receptor-mediated excitotoxicity
[5–7]. Non-receptor-mediated oxidative stress involves
inhibition of cysteine uptake, alterations of intracellular
cysteine homeostasis, glutathione depletion, and ultim-
ately elevation of reactive oxygen species (ROS) activa-
tion inducing neuronal cell death [5, 8–10]. Death of
hippocampal cell following oxidative stress and accumu-
lation of ROS play a role in learning and memory
impairment of brain disorders [11].
Under oxidative neuronal death, the pathways of p38
mitogen-activated protein kinase (MAPK) and
phosphatidylinositol-3 kinase (PI3K) play critical roles in
control of neuronal death and cell survival caused by
glutamate, respectively [6, 12]. Brain-derived neuro-
trophic factor (BDNF) mediates neuronal survival and
neuroplasticity and associated learning and memory, and
its signaling is associated with alteration of the main me-
diators of PI3K pathways [13–15]. Cyclic AMP response
element binding protein (CREB) has multiple roles in
different brain areas, as well as promotion of cell sur-
vival [16, 17] and is involved in memory, learning, and
synaptic transmission in the brain [18, 19].
Studies of the neuroprotection have been performed in
both HT22 cells and middle cerebral artery occlusion
(MCAO)-induced injury [20, 21]. However memory defi-
cits are also frequently noted after stroke. Transient
MCAO induce a progressive deficiency in spatial per-
formance related to impaired hippocampal function [22].
Thus shorter durations of ischemia have been used in
the experiments that aimed to test impaired spatial
learning and memory performance [23].
In traditional literature of Korean/Chinese medicine,
research for screening, evaluating citation and attempt-
ing practical use of herbs has been conducted for devel-
opment of therapeutic strategies [24]. We prepared
multiherb formulae comprising the roots of Polygonum
multiflorum, Rehmannia glutinosa, Polygala tenuifolia,
and Acorus gramineus to increase medicinal efficacy by
systematic investigation of Dongeuibogam, published by
Joon Hur in the early 17th century in Korea. Our aim
was to determine the beneficial effects of herbal mixture
extract on hippocampal neurons, a susceptible cell im-
portant in memory impairment, in HT22 hippocampal
cells and the hippocampus with subsequent memory en-




tetrazolium bromide (MTT), N-acetyl-L-cysteine (NAC),
and β-actin antibody were purchased from Sigma-
Aldrich (St. Louis, MO, USA). BAPTA-AM and EGTA
were purchased from Tocris Bioscience (Ellisville, MO,
USA). Dulbecco’s modified Eagle’s medium (DMEM),
fetal bovine serum (FBS), and other cell culture reagents
were purchased from Gibco-Invitrogen (Carlsbad, CA,
USA). Antibodies recognizing p38, phospho-p38 (pp38,
Thr180/Tyr182), PI3K, and pro-BDNF were supplied by
Santa Cruz Biotechnology (Santa Cruz, CA, USA), and
CREB, phospho-CREB (pCREB, Ser133), and phospho-
PI3K (pPI3K, Tyr458) were supplied by Cell Signaling
(Danvers, MA, USA). Antibody recognizing neuronal
nuclei (NeuN) was supplied by Millipore Corporation
(Billerica, MA, USA), and mature BDNF was supplied by
Abcam (Cambridge, MA, USA). Secondary antibodies
were supplied by Santa Cruz Biotechnology. A FITC
Annexin V apoptosis detection kit was purchased from
BD Bioscience (San Diego, CA, USA). A lactate dehydro-
genase (LDH) cytotoxicity assay kit was purchased from
Promega (Madison, WI, USA), and ROS detection reagent,
5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diace-
tate (carboxy-H2DCFDA), and Hoechst 33342 was pur-
chased from Invitrogen (Carlsbad, CA, USA).
Preparation of four herbal mixture extract
The dried roots of Polygonum multiflorum Thunb.,
Rehmannia glutinosa (Gaertn) Libosch., Polygala tenui-
folia Willd., and Acorus gramineus Soland. were pur-
chased from Dongnam Co. (Busan, Korea) and were
authenticated by Professor Y.W. Choi, Department of
Horticultural Bioscience, College of Natural Resource
and Life Science, Pusan National University. A voucher
specimen (accession number PMCWSD2.1 ~ 2.4) was
deposited at the Plant Drug Research Laboratory of
Pusan National University (Miryang, Korea). Dried pow-
dered Polygonum multiflorum (25.5 kg), Rehmannia glu-
tinosa (9.5 kg), Polygala tenuifolia (7.5 kg), and Acorus
gramineus roots (7.5 kg) were immersed in 450 L of dis-
tilled water and boiled at 120 ± 5 °C for 150 min. The re-
sultant extract was centrifuged (2000 × g for 20 min at
4 °C) and filtered through a 0.2-μm filter. The filtrate
was then concentrated in vacuo at 70 ± 5 °C under re-
duced pressure and then converted into a fine spray-
dried powder at a yielding rate of 4.6 % (2.3 kg) in a
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vacuum drying apparatus. Finally, the solid form of the
spray-dried powder was dissolved with dimethyl sulfoxide
(DMSO) for use as PMC-12 in experiments.
High performance liquid chromatography (HPLC) analysis
and quantification
For analysis of quality and quantity for PMC-12, sample
of 0.5 g dry weight was sonicated in 10 ml MeOH,
filtered through a 0.45 μm membrane filter before
HPLC analysis. HPLC using G1100 systems (Agilent
Technologies, Waldbronn, Germany) was performed
on a Luna C18 column (5 μm, 150 mm × 3.0 mm i.d.
Phenomenex, Torrance, CA, USA) with a mobile phase
gradient of acetonitrile–water (0 to 100) for 35 min. The
injection volume was 10 μl of sample and mobile phase
flow rate 0.4 ml/min with UV detection at 254 nm for
2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside (THS)
and 3′,6-disinapoyl sucrose (DISS) and at 203 nm for
catalpol. Acquisition and analysis of chromatographic
data were performed using Agilent chromatographic
Work Station software (Agilent Technologies). Stock
solutions of THS, DISS, and catalpol were prepared for
quantification of PMC-12. The contents of PMC-12
were determined by regression equations, calculated in
the form of y = ax + b, where x and y were peak area
and contents of the compound. The limits of detection
(LOD) and quantification (LOQ) under the current
chromatographic conditions were determined at a
signal-to-noise ratio of 3 and 10, respectively.
Cell culture
HT22 cells were cultured in DMEM supplemented with
10 % FBS and 1 % penicillin/streptomycin in a 5 % CO2
humidified incubator at 37 °C. The cells were incubated
for 24 h prior to experimental treatments. After incuba-
tion, cells were treated with various concentrations of
PMC-12 for 24 h, followed by exposure to 5 mM glu-
tamate for 24 h. Cells were pretreated with inhibitors for
30 min before addition of PMC-12 and then exposed to
glutamate.
Cell viability assay
HT22 cell survival was assessed using a MTT assay. The
culture medium was replaced with 0.5 mg/ml MTT solu-
tion and then left in a dark place for 4 h at 37 °C. Fol-
lowing incubation, the cells were treated with DMSO in
order to dissolve the formazan crystals. Absorbance was
determined at 595 nm using a SpectraMax 190 spectro-
photometer (Molecular Devices, Sunnyvale, CA, USA).
Results were expressed as a percentage of control.
Determination of cell cytotoxicity
Released LDH from damaged cells was measured for
estimation of cytotoxicity. For induction of maximal cell
lysis, treated cells were lysed with 0.9 % Triton X-100
for 45 min at 37 °C. Supernatant samples were trans-
ferred to a 96-well enzymatic assay plate and reacted
with substrate mix in the dark for 30 min at room
temperature. At the end of that time, samples were
treated with stop solution and read at 490 nm using a
SpectraMax 190 spectrophotometer (Molecular Devices).
Data represent the percentage of LDH released relative to
controls.
Flow cytometric analysis
After treatment, cells were harvested and resuspended
in binding buffer at a concentration of 1x104 cells/ml.
For analysis of cell death types, 100 μl of the solution
was transferred to a flow cytometric tube, followed by
incubation with Annexin V-FITC and propidium iodide
(PI) in the dark at room temperature for 15 min. Subse-
quently, 400 μl of binding buffer was added and analysis
of the samples was performed using a flow cytometer
(FACS Canto™ II; Becton-Dickinson, San Jose, CA,
USA).
ROS measurement
HT22 cells were cultured in 96-well white plates at a
density of 5x103 cells per well. After adherence, cells
were pretreated with PMC-12 for 24 h and then ex-
posed to 5 mM glutamate for 24 h. Treated cells
were washed with PBS. Carboxy-H2DCFDA (20 μM)
(Invitrogen) was applied to the cells, followed by in-
cubation for 1 h in a 37 °C incubator. Fluorescence
was measured using a Mutilabel counter (Perkin
Elmer 1420, MA, USA). Accumulation of intracellular
ROS was observed and photographed under a fluores-
cence microscope (Carl Zeiss Imager M1, Carl Zeiss,
Inc., Gottingen, Germany). In addition, cells were har-
vested, resuspended in 1 ml PBS with 20 μM carboxy-
H2DCFDA (Invitrogen), and then incubated for 1 h at
37 °C. After washing, cellular fluorescence was measured
using a flow cytometer.
Nuclear staining with Hoechst 33342
Apoptosis was investigated by staining the cells with
Hoechst 33342 (Invitrogen). HT22 cells were washed
three times with PBS and then fixed in PBS containing
4 % paraformaldehyde for 25 min at 4 °C. Fixed cells
were washed with PBS and stained with Hoechst
33342 (10 μg/ml) for 15 min at room temperature.
The cells were washed three times with PBS and
mounted using the medium for fluorescence (Vector
Laboratories, Inc.) The cells were observed under a
fluorescence microscope for nuclei showing typical
apoptotic features such as chromatin condensation
and fragmentation. Photographs were taken at a mag-
nification of X 200.
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Western blot analysis
The cells were homogenized with lysis buffer [200 mM
Tris (pH 8.0), 150 mM NaCl, 2 mM EDTA, 1 mM NaF,
1 % NP40, 1 mM PMSF, 1 mM Na3VO4, protease inhibi-
tor cocktail]. Equal amounts of proteins were separated
by 10 or 12 % sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and then transferred to a
nitrocellulose membrane (Whatman GmbH, Dassel,
Germany). The membranes were blocked with 5 % skim
milk in PBST for 1 h, followed by overnight exposure to
appropriate antibodies. Membranes were then incubated
with appropriate horseradish peroxidase-conjugated
antibodies for 1 h. All specific bands were visualized
using an enhanced chemiluminescence system (Pierce
Biotech, Rockford, IL, USA) and imaged using an Image
Quant LAS-4000 imaging system (GE Healthcare Life
Science, Uppsala, Sweden). Results of the Western blot
assay reported here are representative of at least three
experiments.
Focal cerebral ischemia
To confirm beneficial effects of PMC-12 on hippocam-
pal cell, we used middle cerebral artery occlusion
(MCAO) model. Male C57BL/6 mice (20-25 g) were ob-
tained from Dooyeol Biotech (Seoul, Korea). The mice
were housed at 22 °C under alternating 12 h cycles of
dark and light, and were fed a commercial diet and
allowed tap water ad libitum. All experiments were
approved by the Pusan National University Animal Care
and Use Committee. Each group consisted of six mice
and all treatments were administered under isoflurane
(Choongwae, Seoul, Korea) anesthesia, which was pro-
vided using a calibrated vaporizer (Midmark VIP3000,
Orchad Park, OH, USA).
Focal cerebral ischemia was induced by occluding the
middle cerebral artery (MCA) using the intraluminal
filament technique. A fiber-optic probe was affixed to
the skull over the middle cerebral artery for measure-
ment of regional cerebral blood flow using a PeriFlux
Laser Doppler System 5000 (Perimed, Stockholm,
Sweden). Middle cerebral artery occlusion model was
induced by a silicon-coated 4-0 monofilament in the
internal carotid artery and the monofilament was ad-
vanced to occlude the MCA. The filament was with-
drawn 30 min after occlusion and reperfusion was
confirmed using laser Doppler. Mice in the PMC-12
groups received oral administration daily at the doses of
100 and 500 mg/kg for three weeks after MCAO, while
mice in the control and vehicle groups were only given
distilled water at the same intervals.
Immunofluorescence staining
Mice anesthetized with isoflurane received intracardial
perfusion with saline and then 4 % paraformaldehyde in
PBS. Brains were removed, post-fixed in the same fixa-
tive for 4 h at 4 °C, and immersed in 30 % sucrose for
48 h at 4 °C for cryoprotection. Frozen 20 μm-thick sec-
tions were incubated for blocking with a blocking buffer
(1X PBS/5 % normal serum/0.3 % Triton X-100) for 1 h
at room temperature. The sections were incubated with
Fig. 1 HPLC analysis and quantification of PMC-12. HPLC chromatograms of THS, DISS, and catalpol reference (a) and PMC-12 (b) obtained using
a Luna C18 (2) column monitored at 254 nm and eluted with 100 % water to 100 % acetonitrile for 40 at a flow-rate of 1.0 ml/min
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the following primary antibodies to NeuN (Millipore
Corporation), mature BDNF (Abcam), and pCREB (Cell
Signaling) overnight in PBS at 4 °C. After washes with
PBS, the sections were incubated with the fluorescent
secondary antibody (Vector Laboratories, Inc., Burlingame,
CA, USA) at room temperature in the dark, respectively,
and then washed three times with PBS. Subsequently,
slides were mounted in the mounting medium (Vector
Laboratories, Inc.) and captured using a fluorescence
microscope.
Behavioral assessment
Acquisition training for the Morris water maze was per-
formed on four consecutive days from 10 days to seven
days before MCAO (five trials per day) and basal time
was measured at six days before MCAO. The tank had a
diameter of 100 cm and an altitude of 50 cm. The plat-
form was placed 0.5 cm beneath the surface of the water.
Each trial was performed for 90 s or until the mouse ar-
rived on the platform. PMC-12-treated mice received
daily oral administration at the doses of 100 and
500 mg/kg for three weeks after MCAO, while mice in
the control and vehicle groups were only given distilled
water at the same intervals. After final administration,
results of the experiment were recorded using SMART
2.5.18 (Panlab S.L.U.).
Data analysis
All data were expressed as mean ± SEM and analyzed
using the SigmaStat statistical program version 11.2
(Systat Software, San Jose, CA, USA). Statistical compar-
isons were performed using one-way analysis of variance
(ANOVA) for repeated measures followed by Tukey’s
test of least significant difference. A P-value < 0.05 was
considered to indicate a statistically significant result.
The median effective dose (ED50) value of PMC-12
(in vitro experiments) was derived from dose–response
curve.
Results
HPLC analysis of PMC-12
HPLC conditions, particularly the mobile phase and its
elution program, are important for determination of the
compound in the biological matrix. In this study, we
A
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Fig. 2 Protective effects of PMC-12 against glutamate-induced cell death in HT22 cells. Cell viability and toxicity were determined by
MTT (a) and LDH assay (b). Cells were pretreated with 0.01, 0.1, 1, and 10 μg/ml of PMC-12 for 24 h, followed by exposure to 5 mM
glutamate for 24 h. ###P < 0.001 vs. control; *P < 0.05, **P < 0.01 and ***P < 0.001 vs. glutamate-treated cells. All data are represented as
the mean ± SEM of three independent experiments
Table 1 Concentration, calibration curve, regression data, LODs and LOQs for THS, DISS, and catalpol by HPLC
Compounds Wavelength (nm) Concentration (%) Calibration curve r2 LOD (μg/ml) LOQ (μg/ml)
THS 254 3.085 ± 0.271 y = 3284.72x + 2.00 0.999 1.41 4.27
DISS 254 0.352 ± 0.058 y = 4289.06x + 47.95 0.999 0.59 1.79
Catalpol 203 0.785 ± 0.059 y = 1253.49x + 31.37 0.999 0.63 1.91
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found that a mobile phase consisting of acetonitrile
and containing H2O can separate THS, DISS, and
catalpol (Fig. 1). The HPLC conditions developed in
this study produced full peak-to-baseline resolution
of the major active THS, DISS, and catalpol present
in PMC-12. Based on UV maximal absorption, we
detected THS and DISS at 254 nm and catalpol at
203 nm for quantitative analysis. The contents of
THS, DISS, and catalpol in PMC-12 were 3.085 ± 0.271 %,
0.352 ± 0.058 %, and 0.785 ± 0.059 %, respectively. Lin-
ear calibration curve showed good linear regression
(r2 > 0.999) within test ranges; the LOD (S/N = 3) and
the LOQ (S/N = 10) were less than 1.5 and 4.5 μg at
254 nm for THS and DISS and at 203 nm for the cat-
alpol (Table 1).
Pretreatment with PMC-12 reduces glutamate-induced
neuronal toxicity in HT22 cells
Exposure of cells to glutamate resulted in reduced cell
viability of approximately 36.5 % compared with the
control. Pretreatment with PMC-12 at a concentration
range of 0.01 to 10 μg/ml (ED50 = 0.32 μg/ml PMC-12)
resulted in significantly reduced glutamate-induced cyto-
toxicity in a dose-dependent manner (Fig. 2a). The levels
of LDH release showed a significant increase to 77.8 %
after exposure to glutamate, while pretreatment with
PMC-12 resulted in a marked decrease of glutamate-
induced release of LDH (Fig. 2b). These results suggest
that pretreatment with PMC-12 exerts a potent neuro-
protective effect against oxidative toxicity caused by ex-
posure of HT22 cells to glutamate.
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Fig. 3 Protective effect of PMC-12 on types of cell death in HT22 cells. Cells were pretreated with 0.1, 1, or 10 μg/ml PMC-12 for 24 h, followed
by exposure to 5 mM glutamate for 24 h. Representative flow cytometric analysis scatter-grams of Annexin V/PI staining (a) and quantitative
analysis of the histograms (b and c). ###P < 0.001 vs. control; ***P < 0.001 vs. glutamate-treated cells. All data are represented as the mean ± SEM of
three independent experiments
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Pretreatment with PMC-12 inhibits glutamate-induced
apoptotic cell death in HT22 cells
We performed flow cytometry analysis using Annexin
V/PI staining in order to characterize the types of neur-
onal death. Concentrations of 0.1, 1, and 10 μg/ml of
PMC-12 were selected for testing. After exposure to glu-
tamate, cells were likely to undergo apoptotic cell death
rather than necrotic death, however, pretreatment with
PMC-12 resulted in a marked decrease in the apoptotic
population (Fig. 3). These results suggest that pretreat-
ment with PMC-12 exerts a neuroprotective effect
through inhibition of glutamate-induced apoptotic cell
death.
Pretreatment with PMC-12 inhibits glutamate-induced
production of ROS in HT22 cells
Treatment of HT22 cells with glutamate resulted in in-
creased production of ROS. However, pretreatment with
PMC-12 resulted in a significant decrease in ROS pro-
duction, which prevented elevation of ROS level caused
by exposure to glutamate (Fig. 4a). We also performed
staining with Hoechst 33342 to confirm morphological
changes by glutamate-induced oxidative toxicity. Our re-
sult showed that PMC-12 protected against apoptotic
cell death by production of ROS after exposure to glu-
tamate (Fig. 4b). When cells were treated with 10 μM of
intracellular Ca2+ chelator BAPTA-AM and 1.5 mM of
extracellular Ca2+ chelator EGTA, both inhibitors caused
a significant reduction in the levels of glutamate-induced
production of ROS. However, no change in ROS produc-
tion was observed in cells treated with a combination of
Ca2+ chelators and PMC-12 compared to cells treated
with PMC-12 alone followed by exposure to glutamate
(Fig. 5). These results suggest that PMC-12 suppresses
glutamate-induced oxidative stress by blocking ROS pro-
duction, which may be related to an indirect Ca2+
pathway.
Pretreatment with PMC-12 enhances mature BDNF
expression and CREB phosphorylation via p38 MAPK and
PI3K in HT22 cells
Levels of phosphorylated p38 MAPK and dephosphory-
lated PI3K were significantly decreased by treatment
with either PMC-12 or anti-oxidant NAC compared to
glutamate-treated cells. Protein levels of mature BDNF
and CREB phosphorylation were significantly increased
by treatment with either PMC-12 or NAC (Fig. 6a).
When cells were treated with PMC-12, NAC, or intracel-
lular Ca2+ inhibitor BAPTA-AM, combination treatment
resulted in markedly reduced levels of phosphorylated p38
MAPK and dephosphorylated PI3K compared to other
cells. The combination treatment of cells also resulted













































Fig. 4 Protective effect of PMC-12 on ROS generation in glutamate-treated HT22 cells. Cells were pretreated with 0.01, 0.1, 1, or 10 μg/ml of
PMC-12 for 24 h, followed by exposure to 5 mM glutamate for 24 h. The oxidation sensitive fluorescence dye, carboxy-H2DCFDA (20 μM), was
used in measurement of ROS levels. Production of ROS was analyzed using a fluorescence plate reader (a) and fluorescence microscope (b). In
addition, apoptotic nuclei were observed after staining with Hoechst 33342 for detection of apoptosis morphologically (b). ###P < 0.001 vs.
control; **P < 0.01 and ***P < 0.001 vs. glutamate-treated cells. All data are represented as the mean ± SEM of three independent experiments.
Scale bars = 50 μm
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in elevation of decreased protein levels of mature BDNF
and CREB phosphorylation after exposure to glutamate
(Fig. 6b). These results suggest that neuroprotective effects
of PMC-12 may be regulated by both p38 MAPK and
PI3K signaling with mature BDNF expression and CREB
phosphorylation, and these effects may be related to ROS
accumulation and Ca2+ influx.
Treatment with PMC-12 enhances mature BDNF expression
and CREB phosphorylation in the hippocampus of MCAO
mice
At 26 days after MCAO, positive neuronal cells of
pCREB and mature BDNF in the hippocampal CA1 and
dentate gyrus (DG) region were counted after immuno-
fluorescence staining. Post-treatment with PMC-12
followed by MCAO surgery resulted in a significant in-
crease in the number of double-positive cells of pCREB/
NeuN or mature BDNF/NeuN in the CA1 and DG
region of the ipsilateral hippocampus compared to the
MCAO group (Fig. 7). These results suggest a possible
association of the protective effects of PMC-12 with
neuronal mature BDNF expression and CREB phosphor-
ylation in the hippocampus of MCAO mice.
Treatment with PMC-12 ameliorates spatial memory
impairment in MCAO mice
Spatial memory was assessed using the water maze
test. MCAO mice took a longer time on average to
find the platform than the basal group. However,
PMC-12-administered mice attained a significantly
lower time at both concentrations from 22 to 25 days
after MCAO compared to the vehicle group (Fig. 8).
In particular, it has shown that a low dose (100 mg/kg) of
PMC-12 is enough for improvement of the damaged
memory function. These results suggest that treatment
Fig. 6 Protective effects of PMC-12 on regulation of intracellular protein kinases in HT22 cells. Cells were pretreated with 1 μg/ml PMC-12 or
1 mM NAC, followed by exposure to 5 mM glutamate (a). In addition, cells were pretreated with 10 μM BAPTA-AM or NAC for 30 min before
addition of PMC-12 or glutamate (b). The histogram for Fig. 6b was indicated as the mean ± SEM of three independent experiments (c). Equal
amounts of proteins and each sample were subjected to Western blot analysis using the indicated antibodies. Equal protein loading was
confirmed by actin expression. ###P < 0.001 vs. normal control; ***P < 0.001 vs. glutamate-treated groups; $P < 0.05 vs. groups except control and
glutamate-treated groups
Fig. 5 Protective effects of PMC-12 on cellular Ca2+-related ROS
production in HT22 cells. Cells were pretreated with 10 μg/ml
of PMC-12 for 24 h, followed by exposure to 5 mM glutamate
for 24 h. Cells were treated with the specific Ca2+ inhibitors, 1.5 mM
EGTA or 10 μM BAPTA-AM, for 30 min before addition of PMC-12 or
glutamate. ROS production was measured using a fluorescence plate
reader and mean fluorescence intensity was expressed as the
mean ± SEM of three independent experiments. ###P < 0.001 vs.
control; ***P < 0.001 vs. glutamate-treated cells
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with PMC-12 may induce beneficial effects for improve-
ment of memory function in a focal cerebral ischemia
model.
Discussion
Traditional medical literature can be used to identify
and shortlist herbs and combinations of herbs for fur-
ther experimental and clinical research [24]. We have
used a systematic method for screening and evaluating
citations from the traditional Korean medicine literature,
Dongeuibogam. In a screening exercise performed using
HT22 hippocampal cells for selection of functional herbs
on memory impairment, among many herbal candidates,
we found that Polygonum multiflorum exhibited promin-
ent neuroprotective effects.
Our previous results demonstrated that extracts from
Polygonum multiflorum exert significant anti-apoptotic
effects against glutamate-induced neurotoxicity [25, 26]
and protect against cerebral ischemic damage via regula-
tion of endothelial nitric oxide [27]. However, extracts of
Polygonum multiflorum alone had a partial blocking
effect against neuronal damage.
Fig. 7 Protective effects of PMC-12 on expression of both pCREB and mature BDNF in the hippocampus of focal cerebral ischemia in mice at
26 days after MCAO. Photomicrograph (a-b, d-e) and its histogram for pCREB/NeuN (c) and mature BDNF/NeuN double-positive cells (f) in the
DG and CA1 regions of the hippocampus. Total number of pCREB/NeuN and mBDNF/NeuN double-positive cells was significantly increased by
administration of PMC-12 in DG and CA1 compared to the MCAO group. ##P < 0.01 and ###P < 0.001 vs. control; *P < 0.05 and **P < 0.01 vs. MCAO
mice. Scale bar = 100 μm
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To enhance the potential beneficial effects of Polyg-
onum multiflorum, we analyzed 4,014 herbal prescriptions
mentioned in Dongeuibogam and noted 19 multiherb for-
mulae, including the roots of Rehmannia glutinosa, Polyg-
ala tenuifolia, and Acorus gramineus. These 19 multiherbs
are commonly used in treatment of mental and physical
weakness of the elderly.
We prepared PMC-12 with Polygonum multiflorum
base and above multiherb formulae to enhance medical
efficiency. In a further screening exercise performed
using a focal cerebral ischemia model, PMC-12 had
marked effects on the decline of infarct size compared
with Polygonum multiflorum extract alone. Thus, in the
current study, we investigated the beneficial effects of
herbal prescription, PMC-12, on hippocampal neurons
and spatial memory deficits in mice.
Exposure to glutamate causes neuronal cell death via
non-receptor-mediated oxidative stress in hippocampal
HT22 cells [28, 29]. Increased levels of Ca2+ and ROS
caused by exposure to glutamate lead to both apoptotic
and necrotic cell death [6, 30, 31]. Since alteration of
Ca2+ signaling is involved in cell death, it can increase
ROS production [32–34].
In the current study, treatment with PMC-12 resulted
in reduction of apoptotic cell death with suppression of
ROS accumulation; PMC-12 may contribute to neuronal
survival against glutamate-induced oxidative toxicity
related to cellular content of ROS and Ca2+. However, in
treatment with PMC-12, ROS production was not
significantly diminished in a concentration-dependent
manner and cells were effectively protected for an add-
itional 24 after removal of PMC-12. The beneficial effect
of PMC-12 on hippocampal cells may not be attributable
to its direct control of ROS accumulation and Ca2+ in-
flux. With anti-oxidative activities, PMC-12 may contrib-
ute to other protective pathways, including endogenous
kinases.
Neuroprotective effects under oxidative stress are me-
diated by regulation of MAPK and PI3K signaling path-
ways, leading to cell death or survival in a variety of
neurodegenerative disorders [35–37]. In particular, roles
of p38 MAPK signaling in neuronal death [38, 39] and
activation of PI3K in neuroprotection [10, 37] play an
essential role under oxidative stress conditions. Our re-
sults showed that neuroprotective effects of PMC-12 are
regulated by signaling pathways of p38 MAPK and PI3K
against glutamate-induced oxidative cell death.
CREB, an important transcription factor implicated in
control of adaptive neuronal responses, contributes to
several critical functions of BDNF-mediated cell survival
[40, 41]. The impaired CREB phosphorylation in hippo-
campus may be a pathological component in neurode-
generative disorders [42, 43]. BDNF has recently been
recognized as a potent modulator capable of regulating a
wide repertoire of neuronal functions [44]. Among two
forms of extracellular BDNF, pro- and mature BDNF,
mature BDNF is essential in protection of neonatal or
developing brain from ischemia injury as well as neur-
onal cells, whereas pro-BDNF may induce neuronal
death [44–48]. In accordance with previous studies, cells
treated with PMC-12 recovered protein levels of mature
BDNF and CREB phosphorylation caused by glutamate.
These results suggest that neuroprotective effects of
PMC-12 may be regulated by both mature BDNF ex-
pression and CREB phosphorylation.
Memory improvement is indicative of the structural
and functional hippocampal plastic changes including its
expression of BDNF [22]. To confirm involvement of
mature BDNF and CREB activation in neuroprotection
of PMC-12, we performed in vivo study using a mild is-
chemic mouse model [22, 23]. Immunohistochemistry
results of treatment with PMC-12 for three weeks in
MCAO mice indicated significant expression in the CA1
and DG regions of the hippocampus, suggesting that
PMC-12 may prevent neuronal death via signaling
pathways of both mature BDNF expression and CREB
phosphorylation.
In addition, we applied a behavioral test, Morris water
maze, which assesses MCAO-induced deficits of learn-
ing and memory. Previous report showed that a short
duration of 60 min MCAO instead of 2 h does not result
in concomitant sensorimotor deficits in mice [23, 49].
Thus 30 min MCAO was conducted to avoid the influ-
ence of sensorimotor deficit on the performance of the
mice in our Morris water maze test. Treatment with
PMC-12 resulted in attainment of a significantly lower
Fig. 8 Beneficial effects of PMC-12 on the spatial memory function
in MCAO mice. Morris water maze test was performed from 22 d to
25 d after MCAO. Administration of PMC-12 resulted in significantly
improved memory function of MCAO mice during the late phase of
the experiment. There was no significant differences in the results by
two different doses (100 and 500 mg/kg) of PMC-12. Mean ± SEM.
###P < 0.001 vs. control; ***P < 0.001 vs. MCAO mice (vehicle)
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time from 22 to 25 days after MCAO compared with the
vehicle group. These findings suggest that PMC-12 may
be a good candidate for recovery of damaged learning
and memory function in a focal cerebral ischemia
model.
Our study did not investigate the main functional
components of multiherb formula PMC-12. However,
phenolic constituents are well known as major active
components of Polygonum multiflorum [50] and
tetrahydroxystilbene-glucoside identified from this herb
promotes long-term potentiation inductions contributing
to enhancement of learning and memory in mice models
[51, 52]. In line with these studies, our HPLC analysis
also showed that 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-
glucoside is one of the main components of multiherb
formula PMC-12. However, medical herbs have diverse
roles within multiherb formulae according to well-known
perspectives of traditional Korean medicine. Some herbs
target the primary disorder and others aim to alleviate
secondary symptoms such as absorption or counting
undesirable effects of other herbs [24, 53]. PMC-12 may
enhance memory function to target primary neuropro-
tective effects and other secondary symptoms by diverse
roles within multiherb formulae.
Conclusions
PMC-12 protects against hippocampal neuronal cell
death via inhibition of Ca2+-related accumulation of
ROS and these effects regulate through the signaling
pathways of p38 MAPK and PI3K associated with ma-
ture BDNF expression and CREB phosphorylation.
PMC-12 may also modulate recovery of memory func-
tion via mature BDNF and CREB against cerebral ische-
mic stroke. These results have shown that multiherb
formula PMC-12 has potential applications as a useful
therapeutic strategy in memory impairment of brain
disorders.
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